Simple blood tests could catch liver damage early in Doctor's offices

NCT ID NCT05699018

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study aims to see which of two blood tests, eLIFT or FibroMeter, is better at finding advanced liver scarring (fibrosis) in people with fatty liver disease or alcohol-related liver disease. About 1,788 adults from primary care clinics will take both tests. The goal is to improve early detection so patients can get specialist care sooner.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALCOHOLIC LIVER DISEASE (ALD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • ANGERS

    COMPLETED

    Angers, 49000, France

  • BAUGE

    RECRUITING

    Baugé-en-Anjou, 49150, France

  • BECON

    COMPLETED

    Bécon-les-Granits, 49370, France

  • CHU Angers

    ACTIVE_NOT_RECRUITING

    Angers, 49000, France

  • CHU Rennes

    ACTIVE_NOT_RECRUITING

    Rennes, 35033, France

  • COMBOURG

    COMPLETED

    Combourg, 35270, France

  • Chalonnes

    COMPLETED

    Chalonnes-sur-Loire, 49290, France

  • LIFFRE

    COMPLETED

    Liffré, 35340, France

  • Montreuil

    COMPLETED

    Montreuil-Bellay, 49260, France

  • RENNES - Armagnac, Churchill

    COMPLETED

    Rennes, 35000, France

  • RENNES - Kennedy

    COMPLETED

    Rennes, 35000, France

  • SEGRE

    COMPLETED

    Segré, 49500, France

  • Val Couesnon

    COMPLETED

    Val-couesnon, 35560, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.